These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18431085)

  • 1. Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto A; Saitta C; Bitto A; Castaldo M; Cinquegrani M; Bonaiuto M; Cristadoro S; Saitta A
    Aging Clin Exp Res; 2008 Apr; 20(2):171-7. PubMed ID: 18431085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals.
    Campo S; Sardo MA; Bitto A; Bonaiuto A; Trimarchi G; Bonaiuto M; Castaldo M; Saitta C; Cristadoro S; Saitta A
    Clin Chem; 2004 Nov; 50(11):2077-82. PubMed ID: 15364890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome.
    Fan P; Liu HW; Wang XS; Zhang F; Song Q; Li Q; Wu HM; Bai H
    Hum Reprod; 2010 May; 25(5):1288-94. PubMed ID: 20185515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Ala379Val polymorphism of platelet-activating factor acetylhydrolase gene in Chinese patients with pre-eclampsia].
    Su LH; Liu XH; He GL; Gao Q; Bai H; Fan P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 46(1):108-12. PubMed ID: 25807807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.
    Kujiraoka T; Iwasaki T; Ishihara M; Ito M; Nagano M; Kawaguchi A; Takahashi S; Ishi J; Tsuji M; Egashira T; Stepanova IP; Miller NE; Hattori H
    J Lipid Res; 2003 Oct; 44(10):2006-14. PubMed ID: 12867534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
    Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
    Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome.
    Zhang R; Song Q; Liu H; Bai H; Zhang Y; Liu Q; Guan L; Fan P
    Lipids Health Dis; 2017 Mar; 16(1):57. PubMed ID: 28320416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.
    Tambaki AP; Rizos E; Tsimihodimos V; Tselepis AD; Elisaf M
    J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):91-5. PubMed ID: 15309245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
    Kakafika AI; Xenofontos S; Tsimihodimos V; Tambaki AP; Lourida ES; Kalaitzidis R; Cariolou MA; Elisaf M; Tselepis AD
    J Lipid Res; 2003 Oct; 44(10):1919-26. PubMed ID: 12867538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation.
    Okamura K; Miura S; Zhang B; Uehara Y; Matsuo K; Kumagai K; Saku K
    Circ J; 2007 Feb; 71(2):214-9. PubMed ID: 17251670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
    Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
    Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the G994T and R92H genotypes of platelet-activating factor acetylhydrolase with risk of preeclampsia in Chinese women.
    Zhou M; Chen M; Bai H; He GL; Liu QQ; Guan LB; Liu XH; Fan P
    Pregnancy Hypertens; 2020 Apr; 20():19-26. PubMed ID: 32145524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease.
    Unno N; Sakaguchi T; Nakamura T; Yamamoto N; Sugatani J; Miwa M; Konno H
    J Surg Res; 2006 Jul; 134(1):36-43. PubMed ID: 16650870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid.
    Kujiraoka T; Hattori H; Ito M; Nanjee MN; Ishihara M; Nagano M; Iwasaki T; Cooke CJ; Olszewski WL; Stepanova IP; Egashira T; Miller NE
    Atherosclerosis; 2004 Sep; 176(1):57-62. PubMed ID: 15306175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.
    Fan P; Liu H; Wang Y; Zhang F; Bai H
    Reprod Biomed Online; 2012 Feb; 24(2):197-205. PubMed ID: 22197603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome.
    Rizos E; Tambaki AP; Gazi I; Tselepis AD; Elisaf M
    Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):203-9. PubMed ID: 15664305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-individual variability of plasma PAF-acetylhydrolase activity in ARDS patients and PAFAH genotype.
    Li S; Stuart L; Zhang Y; Meduri GU; Umberger R; Yates CR
    J Clin Pharm Ther; 2009 Aug; 34(4):447-55. PubMed ID: 19583678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.